AU7121191A – Diagnostic assay for alzheimer’s disease
– Google Patents
AU7121191A – Diagnostic assay for alzheimer’s disease
– Google Patents
Diagnostic assay for alzheimer’s disease
Info
Publication number
AU7121191A
AU7121191A
AU71211/91A
AU7121191A
AU7121191A
AU 7121191 A
AU7121191 A
AU 7121191A
AU 71211/91 A
AU71211/91 A
AU 71211/91A
AU 7121191 A
AU7121191 A
AU 7121191A
AU 7121191 A
AU7121191 A
AU 7121191A
Authority
AU
Australia
Prior art keywords
alzheimer
disease
diagnostic assay
diagnozing
antigen
Prior art date
1990-02-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71211/91A
Inventor
Peter Davies
Hossein A. Ghanbari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albert Einstein College of Medicine
Original Assignee
Albert Einstein College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1990-02-26
Filing date
1991-02-19
Publication date
1991-10-10
1991-02-19
Application filed by Albert Einstein College of Medicine
filed
Critical
Albert Einstein College of Medicine
1991-10-10
Publication of AU7121191A
publication
Critical
patent/AU7121191A/en
1994-05-26
Assigned to ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
reassignment
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Alteration of Name(s) of Applicant(s) under S113
Assignors: ABBOTT LABORATORIES, ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
G—PHYSICS
G01—MEASURING; TESTING
G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 – G01N31/00
G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
G—PHYSICS
G01—MEASURING; TESTING
G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 – G01N31/00
G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
G01N33/6896—Neurological disorders, e.g. Alzheimer’s disease
G—PHYSICS
G01—MEASURING; TESTING
G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N2800/00—Detection or diagnosis of diseases
G01N2800/28—Neurological disorders
G01N2800/2814—Dementia; Cognitive disorders
G01N2800/2821—Alzheimer
Abstract
Methods of diagnozing Alzheimer’s disease using sandwich immunoassays, and antigen and antibodies related to Alzheimer’s disease.
AU71211/91A
1990-02-26
1991-02-19
Diagnostic assay for alzheimer’s disease
Abandoned
AU7121191A
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US48514990A
1990-02-26
1990-02-26
US485149
1990-02-26
Related Child Applications (1)
Application Number
Title
Priority Date
Filing Date
AU81854/94A
Division
AU8185494A
(en)
1990-02-26
1994-12-30
Diagnostic assay for alzheimer’s disease
Publications (1)
Publication Number
Publication Date
AU7121191A
true
AU7121191A
(en)
1991-10-10
Family
ID=23927071
Family Applications (2)
Application Number
Title
Priority Date
Filing Date
AU71211/91A
Abandoned
AU7121191A
(en)
1990-02-26
1991-02-19
Diagnostic assay for alzheimer’s disease
AU81854/94A
Abandoned
AU8185494A
(en)
1990-02-26
1994-12-30
Diagnostic assay for alzheimer’s disease
Family Applications After (1)
Application Number
Title
Priority Date
Filing Date
AU81854/94A
Abandoned
AU8185494A
(en)
1990-02-26
1994-12-30
Diagnostic assay for alzheimer’s disease
Country Status (7)
Country
Link
EP
(1)
EP0444856B1
(en)
JP
(1)
JP3295098B2
(en)
KR
(1)
KR910021585A
(en)
AT
(1)
ATE157774T1
(en)
AU
(2)
AU7121191A
(en)
CA
(1)
CA2037105C
(en)
DE
(1)
DE69127487T2
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU669872B2
(en)
*
1991-12-24
1996-06-27
University Of Kentucky Research Foundation, The
Detection of alzheimer’s disease and other diseases using a photoaffinity labeling method
Families Citing this family (20)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5811310A
(en)
*
1986-09-30
1998-09-22
Albert Einstein College Of Medicine Of Yeshiva Univ.
The Alz-50 monoclonal antibody and diagnostic assay for alzheimer’s disease
US5429947A
(en)
*
1992-06-17
1995-07-04
Merril; Carl R.
Diagnosing Alzheimer’s disease and schizophrenia
US6610493B1
(en)
1993-06-17
2003-08-26
Brigham And Women’s Hospital
Screening compounds for the ability to alter the production of amyloid-β peptide
US5766846A
(en)
*
1992-07-10
1998-06-16
Athena Neurosciences
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5837672A
(en)
1992-07-10
1998-11-17
Athena Neurosciences, Inc.
Methods and compositions for the detection of soluble β-amyloid peptide
WO1995005604A2
(en)
*
1993-08-13
1995-02-23
Molecular Geriatrics Corporation
Methods for the diagnosis of alzheimer’s disease
ES2155099T3
(en)
1993-10-27
2001-05-01
Elan Pharm Inc
TRANSGENIC ANIMALS THAT HOST APP ALELOS THAT PRESENT A SWEDISH MUTATION.
US7427392B1
(en)
1994-11-14
2008-09-23
Elan Pharmaceuticals, Inc.
Methods for aiding in the diagnosis of alzheimer’s disease by measuring amyloid-β peptide (x-≧41) and tau
US5804560A
(en)
*
1995-01-06
1998-09-08
Sibia Neurosciences, Inc.
Peptide and peptide analog protease inhibitors
US6017887A
(en)
*
1995-01-06
2000-01-25
Sibia Neurosciences, Inc.
Peptide, peptide analog and amino acid analog protease inhibitors
GB2346971B
(en)
*
1999-02-19
2004-07-21
Audrey Ann Coop
Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins
DE10303974A1
(en)
2003-01-31
2004-08-05
Abbott Gmbh & Co. Kg
Amyloid β (1-42) oligomers, process for their preparation and their use
BRPI0619249A2
(en)
2005-11-30
2011-09-20
Abbott Lab
anti-globulin-ß antibodies, antigen-binding fractions thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of making said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
IL297746A
(en)
2005-11-30
2022-12-01
Abbvie Inc
Monoclonal antibodies against amyloid beta protein and uses thereof
US8455626B2
(en)
2006-11-30
2013-06-04
Abbott Laboratories
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1
(en)
2007-02-27
2010-12-09
Abbott Gmbh & Co. Kg
Method for the treatment of amyloidoses
EP2020602A1
(en)
*
2007-08-02
2009-02-04
Araclon Biotech
High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
EP2558494B1
(en)
2010-04-15
2018-05-23
AbbVie Inc.
Amyloid-beta binding proteins
MX358739B
(en)
2010-08-14
2018-09-03
Abbvie Inc Star
Amyloid-beta binding proteins.
CN107849124B
(en)
*
2015-06-05
2021-09-24
基因泰克公司
anti-TAU antibodies and methods of use
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4666829A
(en)
*
1985-05-15
1987-05-19
University Of California
Polypeptide marker for Alzheimer’s disease and its use for diagnosis
CA1339014C
(en)
*
1987-10-08
1997-03-25
Ronald E. Majocha
Antibodies to a4 amyloid peptide
GB8724412D0
(en)
*
1987-10-19
1987-11-25
Medical Res Council
Protein
EP0411974A1
(en)
*
1989-07-05
1991-02-06
N.V. Innogenetics S.A.
Monoclonal antibodies to a neurofibrillary tangle antigen
1991
1991-02-19
AU
AU71211/91A
patent/AU7121191A/en
not_active
Abandoned
1991-02-25
KR
KR1019910003026A
patent/KR910021585A/en
not_active
Application Discontinuation
1991-02-26
EP
EP91301506A
patent/EP0444856B1/en
not_active
Expired – Lifetime
1991-02-26
AT
AT91301506T
patent/ATE157774T1/en
active
1991-02-26
DE
DE69127487T
patent/DE69127487T2/en
not_active
Expired – Fee Related
1991-02-26
JP
JP05311791A
patent/JP3295098B2/en
not_active
Expired – Fee Related
1991-02-26
CA
CA002037105A
patent/CA2037105C/en
not_active
Expired – Fee Related
1994
1994-12-30
AU
AU81854/94A
patent/AU8185494A/en
not_active
Abandoned
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU669872B2
(en)
*
1991-12-24
1996-06-27
University Of Kentucky Research Foundation, The
Detection of alzheimer’s disease and other diseases using a photoaffinity labeling method
Also Published As
Publication number
Publication date
DE69127487T2
(en)
1998-01-08
AU8185494A
(en)
1995-06-08
JP3295098B2
(en)
2002-06-24
EP0444856A3
(en)
1991-12-27
CA2037105A1
(en)
1991-08-27
CA2037105C
(en)
2008-12-09
JPH04216464A
(en)
1992-08-06
EP0444856B1
(en)
1997-09-03
ATE157774T1
(en)
1997-09-15
EP0444856A2
(en)
1991-09-04
DE69127487D1
(en)
1997-10-09
KR910021585A
(en)
1991-12-20
Similar Documents
Publication
Publication Date
Title
AU7121191A
(en)
1991-10-10
Diagnostic assay for alzheimer's disease
AU3287989A
(en)
1989-08-01
Antibodies to a4 amyloid peptide
EP0597829A4
(en)
1992-02-27
Novel monoclonal antibody to novel antigen associated with human tumors.
WO1995018826A3
(en)
1995-09-21
Purified primate ctla-8 antigens and related reagents
AU2843889A
(en)
1989-07-13
Antigen antibody conjugate
CA2021594A1
(en)
1991-01-21
Antibody to human interleukin-6 receptor
AU2460988A
(en)
1989-05-04
Simultaneous immunoassay for the determination of antigens and antibodies
NO950037D0
(en)
1995-01-05
Photoactivation of proteins for conjugate format
EP0584715A3
(en)
1995-02-22
Isolation and culturing of transformed cells and preparation of antibodies against them.
GR3025630T3
(en)
1998-03-31
Monoclonal antibody against human IgE
AU7473087A
(en)
1988-01-07
Apparatus for immunoassay with antibody or antigen attached to walls
CA2008304A1
(en)
1990-07-31
Assay for bone alkaline phosphatase
AU8866791A
(en)
1992-06-25
Monoclonal antibody for use in diagnosing alzheimer's disease, hybridoma secreting said antibody and preparation method therefor
AU7068587A
(en)
1987-10-01
Monoclonal antibody immunoblot assay for antigens
AU8944291A
(en)
1992-06-11
Immunoassay for the determination of anti-hiv antibodies in human samples
EP0460607A3
(en)
1992-04-01
Novel monoclonal antibody to novel antigen associated with human tumors
AU5809290A
(en)
1991-01-10
Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application
AU616667B2
(en)
1991-11-07
Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
AU6873587A
(en)
1987-08-27
Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
EP0287397A3
(en)
1990-11-22
Monoclonal antibody specific to human pancreatic phospholipase a2
AU1042488A
(en)
1988-07-15
Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
EP0485476A4
(en)
1993-03-03
Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
GR3015489T3
(en)
1995-06-30
Monoclonal antibodies and process for the diagnosis of phytophtora infections.
AU3283693A
(en)
1993-08-12
Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
SE8704114D0
(en)
1987-10-22
MONOCLONAL ANTIBODY, A PROCESS FOR ITS PREPARATION AND THE USE THEREOF
None